Matt Kazan provides strategic advice to health plan and life sciences clients navigating the complex legislative and regulatory policy environment, with a particular expertise in Medicare Part D and Medicare Advantage.
Prior to joining Avalere, Matt spent over a decade on the US Senate Committee on Finance health staff under Senators Max Baucus and Ron Wyden. As senior health policy adviser, Matt was the primary policy adviser on policy issues, including Medicare Advantage, Medicare Part D and all drug reimbursement under Medicare, chronic disease, dual eligibles, post-acute care, the Medicare Shared Savings Program, and Medicare and Medicaid program integrity. During his tenure, Matt was involved in a variety of major legislative efforts including the Affordable Care Act, the Bipartisan Budget Act of 2018, the Medicare Access and CHIP Reauthorization Act of 2015, the Children’s Health Insurance Program Reauthorization Act of 2009, and the American Recovery and Reinvestment Act.
Matt holds an undergraduate degree from the University of Denver and a Master of Public Policy from the George Washington University.
For even deeper coverage, download the 2021 Healthcare Industry Outlook document below.